Ultrathin esophagoscopy in screening for Barrett's esophagus at a Veterans Administration Hospital: Easy access does not lead to referrals

American Journal of Gastroenterology

Volumn 103, Issue 1, 2008, Pages 92-97

  Atkinson, Matt ^a   Das, Ananya ^a   Faulx, Ashley ^a   Kinnard, Margaret ^a   Falck Ytter, Yngve ^a   Chak, Amitabh ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BARRETT ESOPHAGUS; CAUCASIAN; DIAGNOSTIC ACCURACY; EDUCATION PROGRAM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; FEMALE; GENDER; GENERAL PRACTITIONER; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OBESITY; PATIENT REFERRAL; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; SEDATION; SMOKING;

BARRETT ESOPHAGUS; EQUIPMENT DESIGN; ESOPHAGOSCOPES; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, VETERANS; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; OHIO; PREVALENCE; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS;

EID: 37849023540     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01501.x     Document Type: Article

References (40)

1. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996 78 : 1820 8.
2. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83 : 2049 53.
3. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002 : 11 235 56.
4. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control 1996 7 : 322 7.
5. Mendes de Almeida JC, Chaves P, Pereira AD, et al. Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Ann Surg 1997 226 : 725 33.
6. Flejou JF. Barrett's oesophagus: From metaplasia to dysplasia and cancer. Gut 2005 54 : 6 12.
7. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986 315 : 362 71.
8. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006 4 : 566 72.
9. Boyer J, Robaszkiewicz M. Guidelines of the French Society of Digestive Endoscopy: Monitoring of Barrett's esophagus. The Council of the French Society of Digestive Endoscopy. Endoscopy 2000 32 : 498 9.
10. Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006 63 : 570 80.
11. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002 97 : 1888 95.
12. Csendes A, Smok G, Burdiles P, et al. Prevalence of Barrett's esophagus by endoscopy and histologic studies: A prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus 2000 13 : 5 11.
13. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 31.
14. Williamson WA, Ellis FH, Gibb SP, et al. Barrett's esophagus: Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991 151 : 2212 6.
15. Lagergren J, Bergstrom R, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000 133 : 165 75.
16. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998 90 : 150 5.
17. Brown LM, Swanson CA, Gridley G, et al. Adenocarcinoma of the esophagus: Role of obesity and diet. J Natl Cancer Inst 1995 87 : 104 9.
18. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997 89 : 1277 84.
19. Lagergren J, Bergstrom R, Lindgren A, et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000 85 : 340 6.
20. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995 4 : 85 92.
21. Kabat GC, Ng SK, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control 1993 4 : 123 32.
22. Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago Workshop. Gastroenterology 2004 127 : 310 30.
23. Wilkins T, Gillies RA. Office-based unsedated ultrathin esophagoscopy in a primary care setting. Ann Fam Med 2005 3 : 126 30.
24. Madhotra R, Mokhashi M, Willner I, et al. Prospective evaluation of a 3.1-mm battery-powered esophagoscope in screening for esophageal varices in cirrhotic patients. Am J Gastroenterol 2003 98 : 807 12.
25. Thota PN, Zuccaro G Jr., Vargo JJ 2nd, et al. A randomized prospective trial comparing unsedated esophagoscopy via transnasal and transoral routes using a 4-mm video endoscope with conventional endoscopy with sedation. Endoscopy 2005 37 : 559 65.
26. Faulx AL, Cantanzaro A, Zyzanski S, et al. Patient tolerance and acceptance of unsedated ultrathin esophagoscopy. Gastrointest Endosc 2002 55 : 620 3.
27. Wildi SM, Wallace MB, Glenn TF, et al. Accuracy of esophagoscopy performed by a non-physician endoscopist with a 4-mm diameter battery-powered endoscope. Gastrointest Endosc 2003 57 : 305 10.
28. Saeian K, Staff DM, Vasilopoulos S, et al. Unsedated transnasal endoscopy accurately detects Barrett's metaplasia and dysplasia. Gastrointest Endosc 2002 56 : 472 8.
29. Jobe BA, Hunter JG, Chang EY, et al. Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening for surveillance for Barrett's esophagus: A randomized and blinded comparison. Am J Gastroenterol 2006 101 : 2693 703.
30. Boolchand V, Faulx A, Das A, et al. Primary care physician attitudes toward endoscopic screening for GERD symptoms and unsedated esophagoscopy. Gastrointest Endosc 2006 63 : 228 33.
31. Vernon SW. Participation in colorectal cancer screening: A review. J Natl Cancer Inst 1997 89 : 1406 22.
32. Chak A, Faulx A, Eng C, et al. Gastroesophageal reflux symptoms in adenocarcinomas of esophagus or cardia. Cancer 2006 107 : 2160 6.
33. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002 123 : 461 7.
34. Haggitt RC, Tryzelaar J, Ellis FH, et al. Adenocarcinoma complicating columnar epithelial lined (Barrett's) esophagus. Am J Clin Pathol 1978 70 : 1 5.
35. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983 198 : 554 65.
36. Smith RRL, Hamilton SR, Boitnott JK, et al. The spectrum of carcinoma arising in Barrett's esophagus. Am J Surg Pathol 1984 8 : 563 73.
37. Rosenberg JC, Budey H, Edwards RC, et al. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 1985 55 : 1353 60.
38. Cameron AJ, Lomboy CT. Barrett's esophagus: Age, prevalence, and extent of columnar epithelium. Gastroenterology 1992 103 : 1241 5.
39. Paraf F, Flejou JF, Pignon JP, et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 1995 19 : 183 91.
40. Eloubeidi M, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 1999 94 : 937 43.